Passive Robots for Stroke Rehabilitation: A Feasibility Study
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT07218276
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Functional Training with SepaRRo and NeuRRoFES — DEVICEParticipants will perform functional movements (e.g., reach for targets) with their extremities. During movements, the devices will be used to assist or resist their motion. Participants may receive biofeedback of their movements to better engage them in training. Participants may receive assistance from the devices (including neuromuscular stimulation) and/or their less-impaired limb.
Study Details
The purpose of this study is to examine the feasibility and effectiveness of a novel, multimodal approach that combines passive devices with noninvasive neuromuscular stimulation for upper extremity rehabilitation after stroke.
Key Dates
- Start date
- Nov 5, 2025
- Status verified
- Nov 2025
- Primary completion
- Oct 1, 2027
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 4 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Robotic InterventionParticipants will receive upper extremity rehabilitation using SepaRRo and NeuRRoFES 2-5 times per week for 2-6 weeks
Primary Outcome Measure
Device Survey For Feasibility [ Time Frame: Post-intervention (immediately following last session of intervention) ]
Central Contacts
- Chandramouli Krishnan, PT, PhD7349364031
- Thomas E Augenstein, PhD7342320898
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan - NeuRRo Lab | Ann Arbor | Michigan | 48108 | Chandramouli Krishnan, PT PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By condition
By specialty
By research site
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2/PHASE3 · Recruiting · DiaMedica Therapeutics Inc · Fairhope, Alabama